BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Song ZQ, Hao F, Min F, Ma QY, Liu GD. Hepatitis C virus infection of human hepatoma cell line 7721 in vitroWorld J Gastroenterol 2001; 7(5): 685-689 [PMID: 11819854 DOI: 10.3748/wjg.v7.i5.685]
URL: https://www.wjgnet.com/1007-9327/full/v7/i5/685.htm
Number Citing Articles
1
Usman Ali Ashfaq, Shaheen N Khan, Zafar Nawaz, Sheikh Riazuddin. In-vitro model systems to study Hepatitis C VirusGenetic Vaccines and Therapy 2011; 9(1) doi: 10.1186/1479-0556-9-7
2
Kun-Peng Fang, Jian-Lin Zhang, Yan-Hong Ren, Ye-Ben Qian. Talin-1 Correlates with Reduced Invasion and Migration in Human Hepatocellular Carcinoma CellsAsian Pacific Journal of Cancer Prevention 2014; 15(6): 2655 doi: 10.7314/APJCP.2014.15.6.2655
3
RNA interference: The story of gene silencing in plants and humansBiotechnology Advances 2008; 26(3): 202 doi: 10.1016/j.biotechadv.2007.12.002
4
Yasmine S El Abd, Ashraf A Tabll, Noha G Bader El Din, Alaa El-Dien S Hosny, Rehab I Moustafa, Reem El-Shenawy, Khaled Atef, Mostafa K El-Awady. Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-391
5
George Y. Wu, Masayoshi Konishi, Cherie M. Walton, Denise Olive, Kazuhiko Hayashi, Catherine H. Wu. A Novel Immunocompetent Rat Model of HCV Infection and HepatitisGastroenterology 2005; 128(5): 1416 doi: 10.1053/j.gastro.2005.03.015
6
Quan-Chu Wang, Qing-He Nie, Zhi-Hua Feng. RNA interference: Antiviral weapon and beyondWorld Journal of Gastroenterology 2003; 9(8): 1657-1661 doi: 10.3748/wjg.v9.i8.1657
7
Ying-Song Wu, Yu Feng, Wen-Qi Dong, Yan-Ming Zhang, Ming Li. A vaccinia replication system for producing recombinant hepatitis C virusWorld Journal of Gastroenterology 2004; 10(18): 2670-2674 doi: 10.3748/wjg.v10.i18.2670
8
Vicky M.-H. Sung, Shigetaka Shimodaira, Alison L. Doughty, Gaston R. Picchio, Huong Can, T. S. Benedict Yen, Karen L. Lindsay, Alexandra M. Levine, Michael M. C. Lai. Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus InfectionJournal of Virology 2003; 77(3): 2134 doi: 10.1128/JVI.77.3.2134-2146.2003
9
Huma Tariq, Sobia Manzoor, Fahed Parvaiz, Farakh Javed, Kaneez Fatima, Ishtiaq Qadri. An overview: In vitro models of HCV replication in different cell culturesInfection, Genetics and Evolution 2012; 12(1): 13 doi: 10.1016/j.meegid.2011.10.009
10
Qin Su, Yong Fu, Yan-Fang Liu, Wei Zhang, Jie Liu, Chun-Mei Wang. Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in cultureWorld Journal of Gastroenterology 2003; 9(5): 921-929 doi: 10.3748/wjg.v9.i5.921
11
Yan-Wei Zhong, Jun Cheng, Gang Wang, Shuang-Shuang Shi, Li Li, Ling-Xia Zhang, Ju-Mei Chen. Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistryWorld Journal of Gastroenterology 2002; 8(5): 863-867 doi: 10.3748/wjg.v8.i5.863
12
Li-Xin Zhu, Jing Liu, Ying-Chun Li, Yu-Ying Kong, Caroline Staib, Gerd Sutter, Yuan Wang, Guang-Di Li. Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoproteinWorld Journal of Gastroenterology 2002; 8(3): 499-504 doi: 10.3748/wjg.v8.i3.499
13
Ashraf A. Tabll, Khaled Atef, Noha G. Bader El Din, Yasmine S. El Abd, Ahmed Salem, Ahmed A. Sayed, Reham M. Dawood, Moataza H. Omran, Mostafa K. El-Awady. IN VITRONEUTRALIZATION OF HCV BY GOAT ANTIBODIES AGAINST PEPTIDES ENCOMPASSING REGIONS DOWNSTREAM OF HVR-1 OF E2 GLYCOPROTEINJournal of Immunoassay and Immunochemistry 2014; 35(1): 12 doi: 10.1080/15321819.2013.779925
14
Tin-Yun Ho, Shih-Lu Wu, I-Lu Lai, Ken-Sheng Cheng, Shung-Te Kao, Chien-Yun Hsiang. An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitorsAntiviral Research 2003; 58(3): 199 doi: 10.1016/S0166-3542(03)00004-4
15
Jian Wang, Gui-Ju Xiang, Bing-Xiang Liu. Effect of alpha 2b interferon on inducement of mIL-2R and treatment of HCV in PBMC from patients with chronic viral hepatitis CWorld Journal of Gastroenterology 2003; 9(4): 751-754 doi: 10.3748/wjg.v9.i4.751